IART
Price
$21.80
Change
+$0.09 (+0.41%)
Updated
Dec 20 closing price
58 days until earnings call
MBOT
Price
$0.97
Change
-$0.00 (-0.00%)
Updated
Dec 20 closing price
65 days until earnings call
Ad is loading...

IART vs MBOT

Header iconIART vs MBOT Comparison
Open Charts IART vs MBOTBanner chart's image
Integra LifeSciences Holdings
Price$21.80
Change+$0.09 (+0.41%)
Volume$1.52M
CapitalizationN/A
Microbot Medical
Price$0.97
Change-$0.00 (-0.00%)
Volume$162.12K
CapitalizationN/A
IART vs MBOT Comparison Chart
Loading...
IART
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MBOT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IART vs. MBOT commentary
Dec 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IART is a Hold and MBOT is a Hold.

COMPARISON
Comparison
Dec 23, 2024
Stock price -- (IART: $21.80 vs. MBOT: $0.97)
Brand notoriety: IART and MBOT are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: IART: 180% vs. MBOT: 92%
Market capitalization -- IART: $2.77B vs. MBOT: $18.57M
IART [@Medical Specialties] is valued at $2.77B. MBOT’s [@Medical Specialties] market capitalization is $18.57M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.06B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IART’s FA Score shows that 1 FA rating(s) are green whileMBOT’s FA Score has 0 green FA rating(s).

  • IART’s FA Score: 1 green, 4 red.
  • MBOT’s FA Score: 0 green, 5 red.
According to our system of comparison, both IART and MBOT are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IART’s TA Score shows that 4 TA indicator(s) are bullish while MBOT’s TA Score has 2 bullish TA indicator(s).

  • IART’s TA Score: 4 bullish, 3 bearish.
  • MBOT’s TA Score: 2 bullish, 4 bearish.
According to our system of comparison, IART is a better buy in the short-term than MBOT.

Price Growth

IART (@Medical Specialties) experienced а -9.28% price change this week, while MBOT (@Medical Specialties) price change was -2.55% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -1.49%. For the same industry, the average monthly price growth was +1.84%, and the average quarterly price growth was +2.97%.

Reported Earning Dates

IART is expected to report earnings on Feb 19, 2025.

MBOT is expected to report earnings on Feb 26, 2025.

Industries' Descriptions

@Medical Specialties (-1.49% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IART($2.77B) has a higher market cap than MBOT($18.6M). MBOT YTD gains are higher at: -40.579 vs. IART (-49.943). IART has higher annual earnings (EBITDA): 256M vs. MBOT (-10.75M). IART has more cash in the bank: 309M vs. MBOT (8.15M). MBOT has less debt than IART: MBOT (245K) vs IART (1.68B). IART has higher revenues than MBOT: IART (1.54B) vs MBOT (0).
IARTMBOTIART / MBOT
Capitalization2.77B18.6M14,909%
EBITDA256M-10.75M-2,381%
Gain YTD-49.943-40.579123%
P/E Ratio41.30N/A-
Revenue1.54B0-
Total Cash309M8.15M3,790%
Total Debt1.68B245K686,531%
FUNDAMENTALS RATINGS
IART vs MBOT: Fundamental Ratings
IART
MBOT
OUTLOOK RATING
1..100
8715
VALUATION
overvalued / fair valued / undervalued
1..100
77
Overvalued
50
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9099
PRICE GROWTH RATING
1..100
6154
P/E GROWTH RATING
1..100
7100
SEASONALITY SCORE
1..100
5095

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

MBOT's Valuation (50) in the Biotechnology industry is in the same range as IART (77) in the Medical Specialties industry. This means that MBOT’s stock grew similarly to IART’s over the last 12 months.

MBOT's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as IART (100) in the Medical Specialties industry. This means that MBOT’s stock grew similarly to IART’s over the last 12 months.

IART's SMR Rating (90) in the Medical Specialties industry is in the same range as MBOT (99) in the Biotechnology industry. This means that IART’s stock grew similarly to MBOT’s over the last 12 months.

MBOT's Price Growth Rating (54) in the Biotechnology industry is in the same range as IART (61) in the Medical Specialties industry. This means that MBOT’s stock grew similarly to IART’s over the last 12 months.

IART's P/E Growth Rating (7) in the Medical Specialties industry is significantly better than the same rating for MBOT (100) in the Biotechnology industry. This means that IART’s stock grew significantly faster than MBOT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
IARTMBOT
RSI
ODDS (%)
Bullish Trend 3 days ago
54%
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
61%
Bearish Trend 3 days ago
89%
Momentum
ODDS (%)
Bearish Trend 3 days ago
74%
Bearish Trend 3 days ago
86%
MACD
ODDS (%)
N/A
Bearish Trend 3 days ago
86%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
70%
Bearish Trend 3 days ago
81%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
71%
Bullish Trend 3 days ago
71%
Advances
ODDS (%)
Bullish Trend 11 days ago
62%
Bullish Trend 3 days ago
71%
Declines
ODDS (%)
Bearish Trend 4 days ago
73%
Bearish Trend 18 days ago
85%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
64%
N/A
Aroon
ODDS (%)
N/A
N/A
View a ticker or compare two or three
Ad is loading...
IART
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MBOT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME29.820.82
+2.83%
GameStop Corp
AAPL254.494.70
+1.88%
Apple
SPY591.157.02
+1.20%
SPDR® S&P 500® ETF Trust
BTC.X95104.940000-2119.789000
-2.18%
Bitcoin cryptocurrency
TSLA421.06-15.11
-3.46%
Tesla

IART and

Correlation & Price change

A.I.dvisor indicates that over the last year, IART has been loosely correlated with LUNG. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if IART jumps, then LUNG could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IART
1D Price
Change %
IART100%
+0.41%
LUNG - IART
39%
Loosely correlated
+3.71%
AORT - IART
36%
Loosely correlated
+1.82%
TFX - IART
33%
Loosely correlated
+1.93%
FLGT - IART
33%
Poorly correlated
-2.19%
MBOT - IART
32%
Poorly correlated
+0.10%
More

MBOT and

Correlation & Price change

A.I.dvisor tells us that MBOT and MASS have been poorly correlated (+33% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MBOT and MASS's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MBOT
1D Price
Change %
MBOT100%
+0.10%
MASS - MBOT
33%
Poorly correlated
+6.19%
NVCR - MBOT
28%
Poorly correlated
+1.32%
TTOO - MBOT
28%
Poorly correlated
+4.76%
IART - MBOT
26%
Poorly correlated
+0.41%
PLSE - MBOT
25%
Poorly correlated
+1.07%
More